• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors.中性粒细胞与淋巴细胞比值可预测胰腺神经内分泌肿瘤的生存率。
Oncol Lett. 2017 Apr;13(4):2454-2458. doi: 10.3892/ol.2017.5716. Epub 2017 Feb 13.
2
Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection.根治性切除术后胰头神经内分泌肿瘤(PNETs)术前主胰管扩张和中性粒细胞与淋巴细胞比值的临床意义。
BMC Endocr Disord. 2019 Nov 12;19(1):123. doi: 10.1186/s12902-019-0454-4.
3
Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.可切除胰腺神经内分泌肿瘤患者术前外周血中性粒细胞/淋巴细胞比值对淋巴结转移的预测价值:一项基于列线图的研究
World J Surg Oncol. 2017 May 30;15(1):108. doi: 10.1186/s12957-017-1169-5.
4
Carbohydrate antigen 19-9 as a prognostic biomarker in pancreatic neuroendocrine tumors.糖类抗原19-9作为胰腺神经内分泌肿瘤的预后生物标志物
Oncol Lett. 2017 Dec;14(6):6795-6800. doi: 10.3892/ol.2017.7071. Epub 2017 Sep 26.
5
Value of markers of systemic inflammation for the prediction of postoperative progression in patients with pancreatic neuroendocrine tumors.系统性炎症标志物对预测胰腺神经内分泌肿瘤患者术后进展的价值。
Front Endocrinol (Lausanne). 2024 Feb 1;15:1293842. doi: 10.3389/fendo.2024.1293842. eCollection 2024.
6
Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.术前中性粒细胞与淋巴细胞比值对可手术切除胰腺神经内分泌肿瘤的预后意义。
Med Sci Monit. 2017 Nov 23;23:5574-5588. doi: 10.12659/msm.907182.
7
Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG).术前单核细胞与淋巴细胞比值及中性粒细胞与淋巴细胞比值与胰腺神经内分泌肿瘤切除术后无复发生存率和总生存率的相关性(美国神经内分泌肿瘤研究组)
J Surg Oncol. 2019 Sep;120(4):632-638. doi: 10.1002/jso.25629. Epub 2019 Jul 24.
8
The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.血浆纤维蛋白原与中性粒细胞-淋巴细胞比值(F-NLR)的联合是可切除性非小细胞肺癌患者的预测因素。
J Cell Physiol. 2018 May;233(5):4216-4224. doi: 10.1002/jcp.26239. Epub 2017 Dec 26.
9
Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.中性粒细胞与淋巴细胞比值在可手术切除食管鳞状细胞癌中的预后作用
World J Gastroenterol. 2015 May 14;21(18):5591-7. doi: 10.3748/wjg.v21.i18.5591.
10
Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.中性粒细胞与淋巴细胞比值在胆囊癌患者中的预后意义。
HPB (Oxford). 2016 Jul;18(7):600-7. doi: 10.1016/j.hpb.2016.03.608. Epub 2016 May 6.

引用本文的文献

1
Prognostic value of neutrophil-lymphocyte ratio in gastroenteropancreatic neuroendocrine neoplasm: a systematic review and meta-analysis.中性粒细胞与淋巴细胞比值在胃肠胰神经内分泌肿瘤中的预后价值:一项系统评价和荟萃分析
PeerJ. 2025 Apr 7;13:e19186. doi: 10.7717/peerj.19186. eCollection 2025.
2
Correlation between Neurotransmitters (Dopamine, Epinephrine, Norepinephrine, Serotonin), Prognostic Nutritional Index, Glasgow Prognostic Score, Systemic Inflammatory Response Markers, and TNM Staging in a Cohort of Colorectal Neuroendocrine Tumor Patients.神经递质(多巴胺、肾上腺素、去甲肾上腺素、血清素)、预后营养指数、格拉斯哥预后评分、全身炎症反应标志物与结直肠类癌患者队列中 TNM 分期的相关性。
Int J Mol Sci. 2024 Jun 26;25(13):6977. doi: 10.3390/ijms25136977.
3
Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms.胃肠胰神经内分泌肿瘤发病机制中与肥胖相关的炎症
Biomedicines. 2022 Oct 21;10(10):2660. doi: 10.3390/biomedicines10102660.
4
Epidemiology and blood parameter changes in Cushing's syndrome - a population-based study.库欣综合征的流行病学和血液参数变化 - 一项基于人群的研究。
Hormones (Athens). 2022 Sep;21(3):467-476. doi: 10.1007/s42000-022-00384-9. Epub 2022 Jul 6.
5
Laboratory variables as predictors of progression in gastroenteropancreatic neuroendocrine tumors in different lines of antineoplastic treatments.实验室变量作为不同抗肿瘤治疗方案中胃肠胰神经内分泌肿瘤进展的预测因子。
Einstein (Sao Paulo). 2022 Jun 1;20:eAO6985. doi: 10.31744/einstein_journal/2022AO6985. eCollection 2022.
6
The Predicting Role of the Neutrophil-to-Lymphocyte Ratio for the Tumor Grade and Prognosis in Pancreatic Neuroendocrine Tumors.中性粒细胞与淋巴细胞比值对胰腺神经内分泌肿瘤分级及预后的预测作用
Diagnostics (Basel). 2022 Mar 18;12(3):737. doi: 10.3390/diagnostics12030737.
7
The Correlation of the Neutrophil-Lymphocyte Ratio and the Platelet-Lymphocyte Ratio With Pathological Findings in Neuroendocrine Tumors.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值与神经内分泌肿瘤病理结果的相关性
Cureus. 2021 Aug 13;13(8):e17164. doi: 10.7759/cureus.17164. eCollection 2021 Aug.
8
Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine Tumors.中性粒细胞在胰腺神经内分泌肿瘤转移演进中的作用
Cancers (Basel). 2021 Jun 2;13(11):2771. doi: 10.3390/cancers13112771.
9
Serum Inflammation-based Scores in Endocrine Tumors.基于血清炎症的内分泌肿瘤评分。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3796-e3819. doi: 10.1210/clinem/dgab238.
10
Pre-operative serum inflammation-based scores in patients with pituitary adenomas.垂体腺瘤患者术前基于血清炎症的评分
Pituitary. 2021 Jun;24(3):334-350. doi: 10.1007/s11102-020-01112-5. Epub 2020 Nov 24.

本文引用的文献

1
A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.偶然发现/有症状的无功能性胰腺神经内分泌肿瘤的临床病理特征与影像特征的综合比较:一项单中心回顾性研究
Pancreatology. 2015 Sep-Oct;15(5):519-524. doi: 10.1016/j.pan.2015.08.009. Epub 2015 Sep 3.
2
Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.中性粒细胞与淋巴细胞比值在胰腺癌中的预后意义:一项荟萃分析。
World J Gastroenterol. 2015 Mar 7;21(9):2807-15. doi: 10.3748/wjg.v21.i9.2807.
3
Biochemical prognostic indicators for pancreatic neuroendocrine tumors and small bowel neuroendocrine tumors.胰腺神经内分泌肿瘤和小肠神经内分泌肿瘤的生化预后指标。
Gland Surg. 2014 Nov;3(4):215-8. doi: 10.3978/j.issn.2227-684X.2014.10.01.
4
Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors.用于预测无功能胰腺神经内分泌肿瘤切除术后预后的肿瘤标志物比较
Surgery. 2014 Dec;156(6):1504-10; discussion 1510-1. doi: 10.1016/j.surg.2014.08.043. Epub 2014 Nov 11.
5
Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group.胰腺神经内分泌肿瘤诊断与管理的共识建议:加拿大国家专家组指南
Ann Surg Oncol. 2015 Aug;22(8):2685-99. doi: 10.1245/s10434-014-4145-0. Epub 2014 Nov 4.
6
Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review.炎症反应相关评分系统在评估胰腺导管腺癌患者预后中的应用:一项系统综述
Hepatobiliary Pancreat Dis Int. 2014 Oct;13(5):474-81. doi: 10.1016/s1499-3872(14)60284-8.
7
WHO 2010 classification of pancreatic endocrine tumors. is the new always better than the old?世界卫生组织2010年胰腺内分泌肿瘤分类。新的就一定比旧的好吗?
Pancreatology. 2014 Nov-Dec;14(6):539-41. doi: 10.1016/j.pan.2014.09.005. Epub 2014 Sep 16.
8
Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy.血液中性粒细胞与淋巴细胞比值可预测接受化疗的晚期胰腺癌患者的生存率。
Ann Surg Oncol. 2015 Feb;22(2):670-6. doi: 10.1245/s10434-014-4021-y. Epub 2014 Aug 26.
9
(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors.(18)氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(F-FDG PET/CT)可用于检测无功能性胰腺神经内分泌肿瘤。
Int J Oncol. 2014 Oct;45(4):1531-6. doi: 10.3892/ijo.2014.2570. Epub 2014 Jul 29.
10
Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy.术前中性粒细胞与淋巴细胞比值可预测接受肾切除术的局限性透明细胞肾癌患者的死亡情况。
Urol Oncol. 2014 Nov;32(8):1277-84. doi: 10.1016/j.urolonc.2014.05.014. Epub 2014 Jul 10.

中性粒细胞与淋巴细胞比值可预测胰腺神经内分泌肿瘤的生存率。

Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors.

作者信息

Luo Guopei, Liu Chen, Cheng He, Jin Kaizhou, Guo Meng, Lu Yu, Long Jiang, Xu Jin, Ni Quanxing, Chen Jie, Yu Xianjun

机构信息

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.

Department of Oncology, Shanghai Medical College of Fudan University, Shanghai 200032, P.R. China.

出版信息

Oncol Lett. 2017 Apr;13(4):2454-2458. doi: 10.3892/ol.2017.5716. Epub 2017 Feb 13.

DOI:10.3892/ol.2017.5716
PMID:28454419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5403377/
Abstract

Although the prognostic role of neutrophil-lymphocyte ratio (NLR) has been confirmed in a variety of tumors, the prognostic role of NLR in pancreatic neuroendocrine tumors (PNETs) has not been examined. The present study was performed to assess the role of NLR as a prognostic factor in patients with PNETs. Clinical data were retrospectively retrieved from a single institution. The best cut-off value for baseline NLR levels was determined by the receiver operating characteristic (ROC) curve and area under the ROC curve. The primary event was overall survival and event times were assessed by the Kaplan-Meier method. Potential factors associated with the elevation of NLR in PNETs were examined. A total of 165 consecutive patients with pathologically confirmed PNETs were included in this study. The cutoff value of NLR was 2.4 by ROC curve (area under ROC curve, 0.70). NLR >2.4 was found to be a poor prognostic factor in the univariate and multivariate analyses. Patients with a NLR value >2.4 had a higher proportion of tumor size at >3 cm (P=0.001), TNM stage III or IV (P=0.019), and G2/G3 (P=0.003). We concluded that NLR is an independent predictor of overall survival for patients with PNETs. Aberrant elevation of NLR identifies high-risk patients with aggressive characteristics.

摘要

尽管中性粒细胞与淋巴细胞比值(NLR)的预后作用已在多种肿瘤中得到证实,但NLR在胰腺神经内分泌肿瘤(PNETs)中的预后作用尚未得到研究。本研究旨在评估NLR作为PNETs患者预后因素的作用。临床数据从单一机构进行回顾性收集。通过受试者工作特征(ROC)曲线及ROC曲线下面积确定基线NLR水平的最佳截断值。主要事件为总生存期,事件发生时间采用Kaplan-Meier法评估。研究了与PNETs中NLR升高相关的潜在因素。本研究共纳入165例经病理证实的连续PNETs患者。根据ROC曲线,NLR的截断值为2.4(ROC曲线下面积为0.70)。在单因素和多因素分析中,NLR>2.4被发现是一个不良预后因素。NLR值>2.4的患者肿瘤大小>3 cm(P=0.001)、TNM分期为III期或IV期(P=0.019)以及G2/G3级(P=0.003)的比例更高。我们得出结论,NLR是PNETs患者总生存期的独立预测因子。NLR的异常升高可识别具有侵袭性特征的高危患者。